injection site for glp 1 New Analysis Clarifies the Dermatologic Risks of GLP-1 RA Therapy How to Inject GLP-1 in

& Catravas, J

mild injection-site reactions in roughly 8 to 12% of users Co-prescriptions / Often combined with TB-500 (thymosin beta-4 fragment) for synergistic tissue repair Monitoring / Track pain scores (0 to 10 NRS) and range of motion weekly

The most commonly reported side effects were injection site reactions (redness, swelling), transient facial flushing, and occasional headache

Immunocytochemistry Immunolabeling of NPCs and derived neurons was accomplished by utilization of a standard two-day protocol with: 15 min fixation in 4% PFA, 10 min permeabilization in 0.1% triton-PBS and 30 min blocking with 5% donkey serum